1-6 of 6
Phyllis A. Svingen
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Phase I and Pharmacologic Study of Infusional Topotecan and Carboplatin in Relapsed and Refractory Acute Leukemia

Scott H. Kaufmann, Judith E. Karp, Louis Letendre, Timothy J. Kottke, Stephanie Safgren, Jackie Greer, Ivana Gojo, Pamela Atherton, Phyllis A. Svingen, David A. Loegering, Mark R. Litzow, Jeff A. Sloan, Joel M. Reid, Matthew M. Ames, Alex A. Adjei, Charles Erlichman
Journal: Clinical Cancer Research
Clin Cancer Res (2005) 11 (18): 6641–6649.
https://doi.org/10.1158/1078-0432.CCR-05-0817
Published: 15 September 2005
View articletitled, Phase I and Pharmacologic Study of Infusional Topotecan and Carboplatin in Relapsed and Refractory Acute Leukemia
Open the PDF for Phase I and Pharmacologic Study of Infusional Topotecan and Carboplatin in Relapsed and Refractory Acute Leukemia in another window
Journal Articles

Components of the Cell Death Machine and Drug Sensitivity of the National Cancer Institute Cell Line Panel

Phyllis A. Svingen, David Loegering, Joe Rodriquez, Xue Wei Meng, Peter W. Mesner, Jr., Susan Holbeck, Anne Monks, Stan Krajewski, Dominic A. Scudiero, Edward A. Sausville, John C. Reed, Yuri A. Lazebnik, Scott H. Kaufmann
Journal: Clinical Cancer Research
Clin Cancer Res (2004) 10 (20): 6807–6820.
https://doi.org/10.1158/1078-0432.CCR-0778-02
Published: 22 October 2004
View articletitled, Components of the Cell Death Machine and Drug Sensitivity of the National Cancer Institute Cell Line Panel
Open the PDF for Components of the Cell Death Machine and Drug Sensitivity of the National Cancer Institute Cell Line Panel in another window
Journal Articles

Comparison of Potential Markers of Farnesyltransferase Inhibition

Alex A. Adjei, Jenny N. Davis, Charles Erlichman, Phyllis A. Svingen, Scott H. Kaufmann
Journal: Clinical Cancer Research
Clin Cancer Res (2000) 6 (6): 2318–2325.
Published: 01 June 2000
View articletitled, Comparison of Potential Markers of Farnesyltransferase Inhibition
Open the PDF for Comparison of Potential Markers of Farnesyltransferase Inhibition in another window
Journal Articles

Characterization of an Ovarian Carcinoma Cell Line Resistant to Cisplatin and Flavopiridol

Keith C. Bible, Scott A. Boerner, Kathryn Kirkland, Kari L. Anderl, Duane Bartelt, Jr., Phyllis A. Svingen, Timothy J. Kottke, Yean K. Lee, Steven Eckdahl, Paul G. Stalboerger, Robert B. Jenkins, Scott H. Kaufmann
Journal: Clinical Cancer Research
Clin Cancer Res (2000) 6 (2): 661–670.
Published: 01 February 2000
View articletitled, Characterization of an Ovarian Carcinoma Cell Line Resistant to Cisplatin and Flavopiridol
Open the PDF for Characterization of an Ovarian Carcinoma Cell Line Resistant to Cisplatin and Flavopiridol in another window
Journal Articles

Induction of Apoptosis in Malignant B Cells by Phenylbutyrate or Phenylacetate in Combination with Chemotherapeutic Agents

Thomas E. Witzig, Michael Timm, Mary Stenson, Phyllis A. Svingen, Scott H. Kaufmann
Journal: Clinical Cancer Research
Clin Cancer Res (2000) 6 (2): 681–692.
Published: 01 February 2000
View articletitled, Induction of Apoptosis in Malignant B Cells by Phenylbutyrate or Phenylacetate in Combination with Chemotherapeutic Agents
Open the PDF for Induction of Apoptosis in Malignant B Cells by Phenylbutyrate or Phenylacetate in Combination with Chemotherapeutic Agents in another window
Journal Articles

Effects of the bcr/abl Kinase Inhibitors AG957 and NSC 680410 on Chronic Myelogenous Leukemia Cells in Vitro

Phyllis A. Svingen, Ayalew Tefferi, Timothy J. Kottke, Gurmeet Kaur, Ven L. Narayanan, Edward A. Sausville, Scott H. Kaufmann
Journal: Clinical Cancer Research
Clin Cancer Res (2000) 6 (1): 237–249.
Published: 01 January 2000
View articletitled, Effects of the bcr/abl Kinase Inhibitors AG957 and NSC 680410 on Chronic Myelogenous Leukemia Cells in Vitro
Open the PDF for Effects of the bcr/abl Kinase Inhibitors AG957 and NSC 680410 on Chronic Myelogenous Leukemia Cells in Vitro in another window